JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) — Capital Reinvestment Ratio
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a Capital Reinvestment Ratio of 0.40x as of June 2025, meaning it reinvests 0% of its operating cash flow ($2.56 Million) in capital expenditures ($1.03 Million). See ZJYL net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Capital Reinvestment Ratio (2020–2025)
This chart tracks JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods. Check JIN MEDICAL INTERNATIONAL LTD. Ordinary cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2020–2025)
Year-by-year Capital Reinvestment Ratio for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2020 to 2025. For live market cap and broader valuation context, see how much is JIN MEDICAL INTERNATIONAL LTD. Ordinary worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | $2.90 Million | $6.63 Million | ▲ +6125.3% |
| 2023 | 0.04x | $3.11 Million | $113.94K | ▲ +44.3% |
| 2022 | 0.03x | $1.58 Million | $40.17K | ▲ +246.3% |
| 2021 | 0.01x | $5.84 Million | $42.88K | ▼ -87.1% |
| 2020 | 0.06x | $2.50 Million | $142.32K | — |